Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2007-07-02
2011-10-04
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S330000, C514S272000, C514S275000
Reexamination Certificate
active
08030487
ABSTRACT:
Compounds having the general structure (A) are provided. The compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, Vegfr and various other specific receptor and non-receptor kinases.
REFERENCES:
patent: 6378526 (2002-04-01), Bowman et al.
patent: 7528143 (2009-05-01), Noronha et al.
patent: 2003/0134838 (2003-07-01), Bornemann et al.
patent: 2004/0106615 (2004-06-01), Cochran et al.
patent: 2004/0167198 (2004-08-01), Wrasidlo et al.
patent: 2005/0234083 (2005-10-01), Chamberlain et al.
patent: 2005/0239852 (2005-10-01), Ciufolini et al.
patent: 2006/0247250 (2006-11-01), Cao et al.
patent: 2006/0292203 (2006-12-01), Dellamary et al.
patent: 2007/0072862 (2007-03-01), Dimauro et al.
patent: 2007/0149508 (2007-06-01), Noronha et al.
patent: 2007/0161615 (2007-07-01), Andrews et al.
patent: WO 0046203 (2000-08-01), None
patent: WO-02/064096 (2002-08-01), None
patent: WO-02/064096 (2002-08-01), None
patent: WO-03/066601 (2003-08-01), None
patent: WO-2006/101977 (2006-09-01), None
patent: WO-2006/101977 (2006-09-01), None
patent: WO-2006/133411 (2006-12-01), None
patent: WO-2007/056023 (2007-05-01), None
patent: WO-2007/056023 (2007-05-01), None
patent: WO-2007/056075 (2007-05-01), None
patent: WO-2007/056075 (2007-05-01), None
patent: WO-2008/008234 (2008-01-01), None
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
Cohen et al., Current Opinion in Chemical Biology, 3,459-465, 1999.
Freshney et al.,Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer et al., Bio/Technology, 1994, 12:320.
Powell et al., British Journal of Dermatology, 141″ 802-810, 1999.
Golub et al., Science, 286, 531-537, 1999.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Wolff Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Krause, D. S. et al. (Jul. 14, 2005). “Tyrosine Kinases as Targets for Cancer Therapy,”N. Eng. J. Med.353(2):172-187.
Shah, N. P. et al. (Jul. 16, 2004). “Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor,”Science305:399-401.
International Search Report mailed on Sep. 21, 2006, for PCT Patent Application No. PCT/US06/009518, filed on Mar. 15, 2006, 2 pages.
Written Opinion mailed on Sep. 21, 2006, for PCT Patent Application No. PCT/US06/009518, filed on Mar. 15, 2006, 4 pages.
International Search Report mailed on Sep. 18, 2006, on for PCT Patent Application No. PCT/US06/022480, filed on Jun. 7, 2006, one page.
Written Opinion mailed on Sep. 18, 2006, for PCT Patent Application No. PCT/US06/022480, filed on Jun. 7, 2006, 3 pages.
International Search Report mailed on Jul. 25, 2007, for PCT Patent Application No. PCT/US06/42838, filed on Oct. 31, 2006, 2 pages.
Written Opinion mailed on Jul. 25, 2007, for PCT Patent Application No. PCT/US06/42838, filed on Oct. 31, 2006, 4 pages.
International Search Report mailed on Jul. 30, 2007, for PCT Patent Application No. PCT/US06/042697, filed Oct. 31, 2006, 2 pages.
Written Opinion mailed on mailed on Jul. 30, 2007, for PCT Patent Application No. PCT/US06/042697, filed Oct. 31, 2006, 4 pages.
International Search Report mailed on Dec. 4, 2007, for PCT Patent Application No. PCT/US07/15357, filed on Jul. 2, 2007, 2 pages.
Written Opinion mailed on Dec. 4, 2007, for PCT Patent Application No. PCT/US07/15357, filed on Jul. 2, 2007, 6 pages.
Non Final Office Action issued on Jan. 12, 2009, for U.S. Appl. No. 11/377,234, filed Mar. 15, 2006, 6 pages.
Non Final Office Action issued on Jul. 23, 2008, for U.S. Appl. No. 11/377,234, filed Mar. 15, 2006, 23 pages.
Non Final Office Action issued Dec. 22, 2008, for U.S. Appl. No. 11/591,252 filed Oct. 31, 2006, 20 pages.
Non Final Office Action issued Jun. 23, 2008, for U.S. Appl. No. 11/591,252 filed Oct. 31, 2006, 21 pages.
Cao Jianguo
Dneprovskaia Elena
Gritzen Colleen
Mak Chi Ching
McPherson Andrew
Balasubramanian Venkataraman
Morrison & Foerster / LLP
TargeGen, Inc.
LandOfFree
2-amino—5-substituted pyrimidine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-amino—5-substituted pyrimidine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino—5-substituted pyrimidine inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4297574